The 7 analysts offering 1 year price forecasts for PCRX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to PCRX in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
PCRX EPS for the last quarter is 0.79 USD despite the estimation of 0.70 USD. In the next quarter EPS is expected to reach 0.78 USD. Track more of Pacira BioSciences, Inc. financials and stay on top of what is up with the company.
According to analysts, PCRX price target is 19.14 USD with a max estimate of 39.00 USD and a min estimate of 8.00 USD. Check if this forecast comes true in a year, meanwhile watch Pacira BioSciences, Inc. stock price chart and keep track of the current situation with PCRX news and stock market news.
We've gathered opinions of 8 analysts rating PCRX stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.